Two key phase III studies of Pfizer oral JAK inhibitor tofacitinib ulcerative colitis have been successful Posted on 2023-04-13
4.7 billion US dollars in the hands of local tyrant Zimmer Biomet in the next few years or start the acquisition war Posted on 2023-04-13
Introduction to the structure and characteristics of high-efficiency and energy-saving low-temperature concentrators Posted on 2023-04-12